tiprankstipranks
Advertisement
Advertisement
Day One Biopharma Earnings Call Highlights Ojemda Surge
PremiumCompany AnnouncementsDay One Biopharma Earnings Call Highlights Ojemda Surge
2M ago
Hold Rating on Day One Biopharmaceuticals as Servier’s $2.5 Billion Takeout Caps Upside at $21.50 Target
Premium
Ratings
Hold Rating on Day One Biopharmaceuticals as Servier’s $2.5 Billion Takeout Caps Upside at $21.50 Target
2M ago
Midday Fly By: Rising oil prices, falling employment sink stocks
Premium
The Fly
Midday Fly By: Rising oil prices, falling employment sink stocks
2M ago
Day One Biopharmaceuticals downgraded to Hold from Buy at JonesResearch
PremiumThe FlyDay One Biopharmaceuticals downgraded to Hold from Buy at JonesResearch
2M ago
Servier to Acquire Day One Biopharmaceuticals in Merger
Premium
Company Announcements
Servier to Acquire Day One Biopharmaceuticals in Merger
2M ago
Day One Biopharmaceuticals trading resumes
Premium
The Fly
Day One Biopharmaceuticals trading resumes
2M ago
Day One Biopharmaceuticals: Ojemda Uptake, Strong 2026 Guidance, and Underappreciated Emi‑Le Catalyst Support Buy Rating
PremiumRatingsDay One Biopharmaceuticals: Ojemda Uptake, Strong 2026 Guidance, and Underappreciated Emi‑Le Catalyst Support Buy Rating
2M ago
Day One Highlights OJEMDA’s EMA Progress, Updates Strategy
Premium
Company Announcements
Day One Highlights OJEMDA’s EMA Progress, Updates Strategy
2M ago
Day One Biopharmaceuticals price target raised to $30 from $29 at Wedbush
Premium
The Fly
Day One Biopharmaceuticals price target raised to $30 from $29 at Wedbush
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100